Secretory Component in Human Amniotic Fluid and Gestational Tissues: A Potential Endogenous Phospholipasa A2 Inhibitor

Abstract

Objective: Prostaglandins (PGs) are essential mediators of labor during human pregnancy. Phospholipase A₂ (PLA₂) provides the essential substrate for PG synthesis through the libertion of arachidonic acid from membrane phospholipid stores. Nonlaboring amniotic fluid (NL-AF) contains secretory component (SC)-like protein(s) that suppress in vitro PLA₂ activity. This study characterizes the biologic activity, identity, and tissue distribution of these protein(s) in NL-AF and gestational tissues.

Methods: Third-trimester NL-AF was collected by amniocentesis, fractionated by ammonium sulfate precipitation, and submitted to an in vitro PLA₂ assay. Identity of the PlA₂ inhibitor in NL-AF was confirmed by Western blot and antibody neutralization studies. Secretory component-immunoreactive proteins were purified by immunoaffinity chromatography and visualized by sodium dodecyl sulfate-gel electrophoresis. Tissue distribution of SC in gestational tissues was determined by immunohistochemistry.

Results: The 100% pellet and supernatant fractions of NL-AF suppressed PLA₂ activity, and this activity was neutralized by a polyclonal antibody to SC. Western blot studies revealed an SC-reactive protein in the 70-80-kD range in the 100% pellet fraction of NL-AF. Two SC-reactive proteins were detected in the 60-80-kD range in the eluate from the SC immunoaffinity column, along with minor proteins of 30 and greater than 100 kD. Immunohistochemical studies revealed SC in placental trophoblast, amniotic membranes, and decidual epithelium.

Conclusions: These results demonstrate that proteins homologous to SC are present in human gestational tissues and possess anti-PLA₂ activity. These proteins may contribute to the maintenance of pregnancy by suppressing local PG production.

Keywords

Secretory component phospholipase A2 prostaglandins labor

Get full access to this article

View all access options for this article.

References

1. Challis JR . Characteristics of parturition. In: Creasy RK , Resnik R , eds. Maternal-fetal medicine. Philadelphia: WB Saunders, 1998;484-497.

2. Hack M , Taylor HG , Klein N , Eiben R , Schatschneider C , Mercuri-Minich M . School-age outcomes in children with birth weights under 750 g. N Engl J Med 1994;331:753-759.

3. Okazaki T , Casey ML , Zokiys JR , MacDonald PC , Johnston JM . Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua. Am J Obstet Gynecol 1981;139:373-381.

4. Liggins Gc , Wilson T . Phospholipases in the control of human parturition. Am J Perinatol 1989;6:153-158.

5. Wilson T , Ganendren R . Serum concentrations of secretory IgA in pregnancies developing at term or preterm. Prostaglandins 1992;44:373-378.

6. Wilson T , Liggins GC , Aimer GP , Skinner SJM . Purification and characterization of a uterine phospholipase inhibitor that loses activity after labour onset in women. Am J Obstet Gynecol 1989;160:602-606.

7. Wilson T , Christie DL . Gravidin , An endogenous inhibitor of phospholipase A-2 activity, is secretory component. Biochem Biophys Res Commun 1991;176:447-452.

8. Cleveland MG , Bakos MA , Pyron DL , Rajaraman S , Goldblum RM . Characterization of secretory component in amniotic fluid: Identification of new forms of secretory IgA. J Immunol 1991;147:181-188.

9. Wilson T . Gravidin : An endogenous inhibitor of phospholipase A2. Gen Pharmacol 1993;24:1311-1318.

10.

10. Cloix JF , Colard O , Rothhut B , Russo-Marie F . Characterization and partial purification of renocortins, two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids. Br J Pharmacol 1983;79:313-321.

11.

11. Bradford M . Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-255.

12.

12. Miele L , Cordella-Miele E , Facchiano A , Mukherjee AB . Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 1988;335:726-730.

13.

13. Laemmli UK . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;277:680-685.

14.

14. Wilson T , Liggins GC , Aimer GP , Skinner SJM . Partial purification and characterization of two compounds which inhibit phospholipase activity in human endometrial cells. Biochem Biophys Res Commun 1985;131:22-29.

15.

15. Schuster-Woldan N , Hilton M , Wilson T . RU-486 inhibits synthesis of an endogenous inhibitor of cell arachidonate release from choriodecidua tissue. Mol Human Reprod 1997;3:743-747.

16.

16. Baumann P , Romero R , Wilson T . Role of gravidin, a phospholipase A2 inhibitor, in uterine contraction. Gynakol Geburtshilfliche Rundsch 1998;38:16-20.

17.

17. Richardson J , Kaushic C , Wira Cr . Estradiol regulation of secretory component: Expression by rat uterine epithelial cells. J Steroid Biochem Mol Biol 1993;47:143-149.

18.

18. Menge AC , Mestecky J . Surface expression of secretory component and HLA class II DR antigen on glandular epithelial cells from human endometrium and two endometrial adenocarcinoma cell lines. J Clin Immunol 1993;13:259-264.

19.

19. Brandtzaet P , Prydz H . Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 1984;311:71-73.

20.

20. Nihei Y , Maruyama K , Endo Y , Sato T , Kobayashi K , Kaneko F . Secretory component (polymeric immunoglobulin receptor) expression on human keratinocytes by stimulation with interferon gamma and differences in response. J Dermatol Sci 1996;11:214-222.